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Abstract 1 
Background and aims: There is conflicting evidence regarding the association 2 
between body temperature and obesity. We aimed to assess the associations 3 
between body temperature and several adiposity and metabolic markers according 4 
to gender and menopausal status in a large population-based sample. 5 
Methods: Data collected between 2009 and 2012 from 4224 participants (mean age 6 
57.3±10.4 years, 2225 women) of the CoLaus study (Lausanne, Switzerland). Body 7 
temperature was measured at the tympanic membrane. 8 
Results: Mean body temperature was 36.1±0.4, 36.4±0.4 and 36.3±0.4°C in men, 9 
premenopausal and postmenopausal women, respectively (p<0.001). In men and 10 
postmenopausal women, body temperature was positively and significantly (p<0.05) 11 
associated with body mass index (Spearman correlation coefficients 0.157 and 12 
0.083, respectively), waist (r=0.163 and r=0.104), waist to hip ratio (r=0.187 and 13 
r=0.132), body area (r=0.094 and r=0.085), resting heart rate (r=0.227 and r=182), 14 
glucose (r=0.104 and r=0.088) and insulin (r=0.148 and r=0.117). Except for body 15 
area and BMI in postmenopausal women, all associations remained significant after 16 
multivariable adjustment. In premenopausal women, body temperature was 17 
positively associated with resting heart rate (r=0.140) and insulin (r=0.170), and no 18 
significant associations were found after multivariable adjustment.  19 
Conclusion: Body temperature is strongly associated with obesity markers in men 20 
and postmenopausal women. The absence of association in premenopausal 21 
women might be due to the influence of the menstrual cycle. 22 
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Introduction 23 
Body temperature has been used to assess and monitor disease since the 24 
Greek Antiquity (1). Body temperature is controlled by the thermoregulatory center 25 
located in the anterior hypothalamus and results from the complex balance between 26 
metabolic processes, muscle activity, and possibly the microbiome (2). Body 27 
temperature is also influenced by the external environment via radiation or 28 
conduction (3). For adequate body functioning, body temperature has to be kept 29 
constant within a narrow range, at the cost of a significant metabolic expense (4, 5). 30 
Body temperature varies according to physiological (gender, age and menstrual 31 
cycle) (6) and pathological (infection, inflammation and neoplasia) (7) conditions, 32 
and can also be modulated by the consumption of drugs such as paracetamol, 33 
nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids. 34 
Among the physiological determinants of body temperature, body mass index 35 
(BMI) has been shown to be positively associated with body temperature in some 36 
studies (8-10) but not in others (11-13). A better insulation due to a thicker layer of 37 
subcutaneous adipose tissue could explain the higher temperature among the 38 
obese (14, 15). Importantly, most studies were conducted using small sample sizes 39 
(42 women and 18 men for (11)) or using devices such as swallow able pill-size 40 
sensors, which are not easily applicable in large samples (9, 13). Indeed, with the 41 
exception of a large American study (10) and a Swedish study conducted in the 42 
eighties among 816 men (8), no study assessed the association between body 43 
temperature and obesity or metabolic markers in the general population. 44 
 We thus aimed to assess the associations between body temperature and 45 
adiposity and metabolic markers according to gender and menopausal status in a 46 
large population-based sample. 47 
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Methodology 48 
Study design 49 
The CoLaus Study (www.colaus-psycolaus.ch) is a prospective study 50 
designed to assess the prevalence of cardiovascular risk factors and to identify new 51 
molecular determinants of cardiovascular disease in the population from Lausanne 52 
(Switzerland). The baseline and the follow-up methodologies of the CoLaus study 53 
have been reported previously (16, 17). Briefly, recruitment began in June 2003 and 54 
ended in May 2006. The follow-up visit was performed between April 2009 and 55 
September 2012 and was similar to the baseline evaluation. As body temperature 56 
was collected only at the follow-up visit, only data from this visit was used. 57 
Anthropometric data 58 
Participants were asked to attend the outpatient clinic at the Lausanne 59 
university hospital in the morning after an overnight fast. Data were collected by 60 
trained field interviewers in a single visit lasting about 60 min. Participants had to be 61 
fasting, take their medication as usual, avoid strenuous physical activity during the 62 
previous 12 h and abstain from consuming caffeine or alcohol-containing beverages 63 
during 24 h before the analysis. 64 
Body weight and height were measured with participants standing without 65 
shoes in light indoor clothing. Body weight was measured in kilograms to the nearest 66 
0.1 kg using a Seca™ scale (Seca, Hamburg, Germany). Height was measured to 67 
the nearest 5 mm using a Seca™ height gauge (Seca, Hamburg, Germany). BMI 68 
was defined as weight (kg) / height2 (m2). Underweight was defined as BMI<18.5 69 
kg/m2; normal weight as BMI ≥18.5 and <25 kg/m2; overweight as BMI ≥25 and 70 
<30 kg/m2 and obesity as BMI ≥30 kg/m2. 71 
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Waist circumference was measured twice with a non-stretchable tape over 72 
the unclothed abdomen at the mid-point between the lowest rib and the iliac crest. 73 
Hip circumference was also measured twice at the greater trochanters. For waist 74 
and hip, the mean of the two measurements was used and waist-to-hip ratio (WHR) 75 
was calculated.  76 
Fat mass was assessed by electrical bioimpedance in the lying position after 77 
a 5-min rest using the Bodystat® 1500 body mass analyzer (Bodystat Ltd, Isle of 78 
Man, England). This device has been shown to correlate well (r=0.968) with 79 
measurements from dual energy X-ray absorptiometry (DEXA) (18). In a subset of 80 
794 CoLaus women who had also their body composition assessed by DEXA, the 81 
correlation between fat mass estimated by bioimpedance and DEXA was 0.852 82 
(p<0.001). All metallic adornments were removed, and measurement was 83 
performed after a 5-min rest in the lying position. The electrodes were positioned in 84 
the right side of the body according to the manufacturer’s instructions. Care was 85 
taken to ensure that the participants did not touch any metallic component of the 86 
bed and that the inner part of the thighs did not touch each other. Results were 87 
obtained as percentage (%BF); body fat mass was calculated as weight × %BF and 88 
expressed in kg. Non-fat mass was obtained by subtracting body fat mass from body 89 
weight. (Non) fat mass indexes were calculated as (non) body fat mass (kg) / height2 90 
(m2). Body area was assessed using the method of Mosteller (19). 91 
Temperature measurement 92 
Body temperature was measured in degrees Celsius (°C) to the nearest 93 
0.1°C using a tympanic thermometer (Genius™ 2, Covidien, Dublin, Ireland) 94 
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according to the manufacturer’s instructions. The measurement was performed in a 95 
temperature-controlled room ~20 minutes after the participant’s admittance.  96 
Other data 97 
Smoking status was categorized into never, former and current smoker. 98 
Menopause was defined as the absence of menstruations for >1 year. All drugs 99 
(prescribed or over the counter) were systematically screened for acetaminophen, 100 
NSAIDs or corticosteroids. Resting heart rate was measured thrice on the right arm, 101 
after at least 10 minutes rest in the seated position, using an Omron® HEM-907 102 
automated oscillometric sphygmomanometer (Matsusaka, Japan). Values 103 
averaged between the last two readings were used. 104 
Most biological assays were performed by the clinical laboratory of the 105 
Lausanne university hospital on fresh blood samples within 2 hours of blood 106 
collection. The following analytical procedures (with maximum inter and intra-batch 107 
CVs) were used on cobas® 8000, Roche Diagnostics, Basel, Switzerland: glucose 108 
by hexokinase (1.6%; 0.8%); high sensitive CRP by immunoturbidimetry HS (8.0%; 109 
7.4%); insulin by ECLIA (electrochemiluminescence method) (3.7%; 1.5%). Care 110 
was taken that no hemolysis was present so not to bias the results. The assay has 111 
been validated and is used for diagnostic procedures, and the technical 112 
documentation can be obtained from the authors upon request. 113 
Inclusion and exclusion criteria 114 
Participants were excluded if they 1) missed data for temperature; 2) missed 115 
data for BMI, waist and hip; 3) reported regular or occasional use of acetaminophen, 116 
NSAIDs or corticosteroids; 4) presented with an inflammatory syndrome, defined as 117 
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a high-sensitivity C-reactive protein (hs-CRP) level ≥20 mg/l, and 5) missed data 118 
regarding menopausal status (women only). For sensitivity analyses, participants 119 
were further excluded if they missed data for bioimpedance. 120 
Statistical analysis 121 
Statistical analyses were performed with Stata® version 14.1 (Stata 122 
Corporation, College Station, TX, USA). As body composition and adiposity markers 123 
differ considerably by gender, analyses were stratified by gender. As menstrual 124 
cycle influences body temperature in women, a further stratification on menopausal 125 
status was performed. Due to their distribution, hs-CRP and insulin were log 126 
transformed prior to analyses. Results were expressed as mean±standard deviation 127 
for continuous data or number of participants (percentage) for categorical data. 128 
Bivariate analyses were performed using Student's t-test or analysis of variance for 129 
continuous data and chi-square test for categorical data. Bivariate associations 130 
between temperature and adiposity and metabolic markers were assessed by 131 
Spearman correlation. Multivariable associations between body temperature and 132 
continuous markers were assessed using linear regression and the results were 133 
expressed as standardized coefficients, which can be interpreted as multivariable-134 
adjusted correlation coefficients. Multivariable associations between body 135 
temperature and BMI categories were assessed using analysis of variance and 136 
results were expressed as multivariable-adjusted mean±standard error; test for a 137 
linear trend was performed using command contrast p. of Stata®. Statistical 138 
significance was considered for a two-sided test with p <0.05. 139 
Ethical statement 140 
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The institutional Ethics Committee of the University of Lausanne, which 141 
afterwards became the Ethics Commission of Canton Vaud (www.cer-vd.ch) 142 
approved the baseline CoLaus study (reference 16/03, decisions of 13th January 143 
and 10th February 2003); the approval was renewed for the first follow-up (reference 144 
33/09, decision of 23rd February 2009). The full decisions of the CER-VD can be 145 
obtained from the authors upon request. The study was performed in agreement 146 
with the Helsinki declaration and its former amendments, and in accordance with 147 
the applicable Swiss legislation. All participants gave their signed informed consent 148 
before entering the study.  149 
 150 
Results 151 
Sample selection and characteristics 152 
The selection procedure is summarized in Figure 1. Of the initial 5064 153 
participants, 4224 (83.4% of the initial sample) were retained for the main analysis. 154 
A further 731 participants (14.4%) had no bioimpedance data, leaving 3493 155 
participants (69% of the initial sample size) for sensitivity analysis. 156 
The characteristics of the included and the excluded participants are 157 
summarized in Supplementary table 1. Excluded participants were older, had a 158 
higher body temperature, were more frequently women or presented with diabetes, 159 
had higher BMI, waist and hip levels and had higher hs-CRP and insulin levels. The 160 
characteristics of the sample according to gender and menopausal status are 161 
summarized in table 1. 162 
Association of body temperature with adiposity and metabolic markers 163 
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The bivariate associations of body temperature with adiposity and metabolic 164 
markers, stratified by gender and menopausal status, are summarized in table 2. 165 
Body temperature was positively associated with WHR, resting heart rate and insulin 166 
in both genders. In men and postmenopausal women, body temperature was 167 
positively associated with BMI, waist, body area and glucose level. Positive 168 
associations between body temperature and age, hip and hs-CRP levels were also 169 
observed in men. In premenopausal women, body temperature was negatively 170 
associated with age. 171 
The multivariable analysis of the associations of body temperature with 172 
adiposity markers, stratified by gender and menopausal status, are summarized in 173 
table 3. The associations were adjusted for age, resting heart rate, hs-CRP and 174 
insulin. In men and postmenopausal women, body temperature was positively 175 
associated with waist and WHR, and with BMI in men; no associations were found 176 
between body temperature and hip or body area. In premenopausal women, no 177 
associations were found between body temperature and all obesity markers studied 178 
(table 3). The associations between heart rate and body temperature remained 179 
significant irrespective of the obesity marker considered; the association between 180 
insulin levels and body temperature remained significant in both genders, while the 181 
association between hs-CRP and body temperature was only significant in men. 182 
(supplementary table 2). 183 
The bivariate and multivariable associations of body temperature with BMI 184 
categories are summarized in Figure 2. In men and postmenopausal women, an 185 
increase in body temperature was found from underweight to obese participants 186 
after adjusting for age, resting heart rate, hs-CRP and insulin. In premenopausal 187 
women, no differences in body temperature were found between BMI categories. 188 
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Sensitivity analyses 189 
The bivariate and multivariable associations of body temperature with body 190 
composition, stratified by gender and menopausal status, are summarized in 191 
supplementary table 3. On bivariate analysis, body temperature increased with fat 192 
mass (% weight, kg and kg/m2) in men and postmenopausal women. Similar 193 
associations were obtained after multivariable analysis adjusting for age, resting 194 
heart rate, hs-CRP and insulin in men, while the associations in postmenopausal 195 
women were no longer significant.  196 
Discussion 197 
To our knowledge, this is the second largest study assessing the association 198 
between body temperature and obesity markers. Our results show that in men and 199 
in postmenopausal women, body temperature is positively associated with obesity 200 
markers, while in premenopausal women no significant association was found after 201 
multivariable adjustment. 202 
Body temperature and anthropometric markers 203 
BMI, waist, hip and WHR were positively associated with body temperature 204 
in men and postmenopausal women. A positive association between BMI and body 205 
temperature had already been reported in some studies (8-10), but not in others 206 
(11-13). A possible explanation for the lack of association in the last studies is that 207 
they were conducted in small samples and had thus a reduced statistical power. 208 
The fact that body temperature was also positively associated with waist and WHR 209 
further suggests it is increased adiposity that leads to a higher body temperature. 210 
Indeed, in the sensitivity analyses, fat mass index (kg/m2) showed the strongest 211 
association with body temperature in men (Supplementary table 3). 212 
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As obese subjects have a larger body surface area, loss of temperature to 213 
the environment would be more important in obese. Still, on bivariate analysis, a 214 
positive association between body temperature and body surface area was found, 215 
but this association was no longer significant after multivariable adjustment. Overall, 216 
our results suggest that the increase body area of obese subjects does not influence 217 
significantly their temperature. 218 
Body temperature and metabolic markers 219 
The chronotropic effect of temperature has been widely documented (20). A 220 
study by Jose et al. identified a 7.15 ± 0.19 bpm increase per 1°C elevation in 221 
internal temperature in humans (21). Heart rate is also associated with obesity: 222 
autonomic regulation towards sympathetic activation with or without simultaneous 223 
parasympathetic inhibition in obese subjects compared to lean peers is described 224 
(22).  225 
A strong association between glucose or insulin levels with body temperature 226 
was found. The association between body temperature and insulin persisted after 227 
adjustment for obesity markers in women and to a lesser degree in men, a finding 228 
also reported elsewhere (23). Overall, our results suggest that insulin could exert a 229 
thermogenic effect independently of obesity levels, possibly by direct interaction 230 
with warm-sensitive neurons stimulating active brown adipose tissue (BAT) (23). 231 
BAT activity was not assessed in this study. However, there is a known inverse 232 
relationship between BAT activity and adiposity, so it is unlikely that BAT activation 233 
would explain the higher temperature observed with obesity in this population. 234 
No associations between body temperature and obesity or metabolic markers 235 
were found in premenopausal women. The most likely explanation is that menstrual 236 
Page 13 of 19 
cycle has a stronger effect than the markers studied. Indeed, in young women, 237 
fluctuations in body temperature between the luteal and follicular phases may be 238 
greater than 0.5 °C, which would cancel out smaller variations due to other factors. 239 
Conversely, after menopause, body temperature decreases over the whole day 240 
(24), thus allowing the detection of smaller differences.  241 
Thus, the higher temperature observed among obese subjects could be due 242 
to several mechanisms. First, obese subjects have a higher resting metabolic rate 243 
(9), a feature also observed in this study by the positive association between resting 244 
heart rate and body temperature. Adipose tissue is a complex, highly active 245 
endocrine organ, secreting hormones such as leptin, adiponectin and cytokines 246 
(adipokines) (25). These hormones have a strong effect on thermogenesis and 247 
energy homeostasis: leptin has a thermogenic effect via increased heat production 248 
in skeletal muscle (26, 27), and many hypothalamic neurons involved in regulating 249 
non-shivering thermogenesis are also leptin sensitive (28). Finally, large-scale 250 
alterations of the gut microbiota are associated with obesity and microbiota 251 
composition changes with weight loss (29). Gut microbiota can affect host 252 
metabolism via signaling pathways in the gut, with effects on inflammation, insulin 253 
resistance and deposition of fat stores (30).  Accordingly, one could speculate that 254 
there could be an indirect relationship between intestinal microbiota composition 255 
and thermal homeostasis in humans, as recently described in mice (31).  256 
Body temperature and age 257 
In contrast to the study of Waalen (10), we found a positive correlation 258 
between body temperature and age in men. The higher prevalence of obesity with 259 
age could explain this correlation. However, it is not excluded that very old men do 260 
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have a lower body temperature; the population over 80 years of age was not 261 
included in our study. By contrast, the temperature decreases with the years in 262 
women. This observation can be reinforced with the beginning of menopause, with 263 
a lower body temperature linked to the disappearance of the menstrual cycle. 264 
Study strengths and limitations  265 
 This study was conducted in a general population, allowing the generalization 266 
of the results to similar populations of Caucasian descent. Its large sample size and 267 
the variety of data collected also allowed assessing the associations between body 268 
temperature and a range of obesity and metabolic markers. 269 
This study also has some limitations. Firstly, body temperature was assessed 270 
using a tympanic thermometer on a single occasion, while the gold standard for 271 
clinical thermometry is the pulmonary artery catheter thermometer (32). Still, such 272 
measure would be unethical to perform in free-living, healthy subjects, and it has 273 
been shown that non-invasive, tympanic membrane measurement accurately 274 
assesses core body temperature compared to reference methods (33-35). 275 
Secondly, no information about the follicular phase in women was documented; 276 
hence, the associations in premenopausal women were blunted as no adjustment 277 
for follicular phase was possible. Future studies on this topic should gather 278 
information regarding follicular phase to identify determinants of body temperature 279 
in this group. Thirdly, no information regarding the thyroid hormone status was 280 
collected or about polycystic ovarian syndrome in women was documented. Finally, 281 
beta blocker treatment was not considered in the analysis; beta blockers have been 282 
shown to increase core temperature in animal models (36). Since beta blockers 283 
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reduce heart rate, one may speculate that the effect in humans would be to 284 
decrease metabolism and body temperature (37). 285 
Conclusion  286 
Body temperature is associated with obesity markers in men and 287 
postmenopausal women. The absence of association between body temperature 288 
and adiposity markers in premenopausal women might be due to the menstrual 289 
cycle. 290 
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Figure legends 407 
Figure 1. Selection procedure. BMI, body mass index; NSAIDs, nonsteroidal anti-408 
inflammatory drugs. § women only. 409 
Figure 2. Association of body temperature with body mass index categories, 410 
stratified by gender and menopausal status, CoLaus study, Lausanne, 2009-2012.  411 
 
